A narcotic antagonist similar in action to NALOXONE. It is used to remobilize animals after ETORPHINE neuroleptanalgesia and is considered a specific antagonist to etorphine.
Diprenorphine has been studied across 16 research domains including 💊 Pain, ⏳ Longevity & Aging, 😴 Sleep, 🔬 Oncology, 🧠 Focus & Attention. The primary research focus is 💊 Pain with 79% of studies addressing this area.
The following compounds share molecular targets with Diprenorphine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Diprenorphine is generated deterministically from 295 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.